Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 12 | 2024 | 284 | 1.390 |
Why?
|
| Antibodies, Neutralizing | 15 | 2024 | 303 | 1.220 |
Why?
|
| Neutralization Tests | 8 | 2024 | 108 | 0.820 |
Why?
|
| Spike Glycoprotein, Coronavirus | 8 | 2024 | 101 | 0.810 |
Why?
|
| HIV-1 | 6 | 2023 | 1260 | 0.690 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 2023 | 36 | 0.470 |
Why?
|
| HIV Infections | 9 | 2023 | 5097 | 0.440 |
Why?
|
| AIDS Vaccines | 2 | 2023 | 152 | 0.370 |
Why?
|
| Cross Reactions | 3 | 2022 | 44 | 0.300 |
Why?
|
| Epitopes | 3 | 2022 | 97 | 0.290 |
Why?
|
| Humans | 19 | 2024 | 14537 | 0.280 |
Why?
|
| Immune Evasion | 3 | 2022 | 31 | 0.280 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 231 | 0.260 |
Why?
|
| Laboratories | 1 | 2024 | 47 | 0.230 |
Why?
|
| HIV Antibodies | 5 | 2023 | 247 | 0.220 |
Why?
|
| Antibody Formation | 1 | 2023 | 61 | 0.220 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2023 | 22 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 4 | 2023 | 142 | 0.190 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2020 | 6 | 0.180 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 265 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 77 | 0.170 |
Why?
|
| Animals | 4 | 2024 | 1081 | 0.170 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2019 | 40 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2019 | 155 | 0.140 |
Why?
|
| Whooping Cough | 1 | 2016 | 36 | 0.130 |
Why?
|
| Mutation | 3 | 2023 | 306 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2016 | 45 | 0.130 |
Why?
|
| Vaccination | 3 | 2023 | 365 | 0.120 |
Why?
|
| Hospitalization | 1 | 2016 | 418 | 0.110 |
Why?
|
| Female | 5 | 2023 | 9103 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2024 | 21 | 0.060 |
Why?
|
| Male | 3 | 2023 | 6754 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 81 | 0.060 |
Why?
|
| World Health Organization | 1 | 2024 | 137 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2023 | 11 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2023 | 39 | 0.050 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2023 | 52 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 42 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2023 | 45 | 0.050 |
Why?
|
| Antibodies | 1 | 2022 | 25 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 15 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 16 | 0.050 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 39 | 0.050 |
Why?
|
| Pregnancy | 2 | 2019 | 1862 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2021 | 4 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 4 | 0.050 |
Why?
|
| Antibody Affinity | 1 | 2021 | 11 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 10 | 0.050 |
Why?
|
| Ferrets | 1 | 2021 | 1 | 0.050 |
Why?
|
| Safety | 1 | 2021 | 34 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2021 | 54 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 45 | 0.050 |
Why?
|
| Adult | 2 | 2023 | 5913 | 0.050 |
Why?
|
| Blood Donors | 1 | 2021 | 19 | 0.050 |
Why?
|
| Biomarkers | 1 | 2022 | 327 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2021 | 272 | 0.050 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 103 | 0.040 |
Why?
|
| Hypergammaglobulinemia | 1 | 2019 | 3 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 296 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 819 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2016 | 16 | 0.030 |
Why?
|
| Bordetella pertussis | 1 | 2016 | 29 | 0.030 |
Why?
|
| South Africa | 2 | 2021 | 7596 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 104 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 167 | 0.030 |
Why?
|
| Middle Aged | 1 | 2023 | 3601 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 1479 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 685 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 276 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 2244 | 0.020 |
Why?
|